2021 annual financial data

Ovid Therapeutics 2021 Operating margin

Direct answer

Operating margin was 59.61%.

Operating income was 124.21M USD and net income was 122.83M USD.
Operating cash flow was 118.61M USD.

Get free Ovid Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
208.38M USD
Operating income
124.21M USD
Net income
122.83M USD
Operating cash flow
118.61M USD